ICER drug prices: baxdrostat, lorundrostat placeholder, and generic comparators
“For baxdrostat, we used the wholesale acquisition cost (WAC) price from RedBook ($900 for 30 tablets). Given that baxdrostat was recently launched, and no information is available to inform a discount from WAC, the WAC price was used as the net price. For lorundrostat, we used the baxdrostat WAC price as a placeholder price. For comparator drugs (spironolactone, eplerenone, and amiloride) we obtained net pricing estimates from Redbook based on the median cost (WAC) across all generic versions.” (opens the source at this quote in a new tab)
“We used the net prices and the threshold prices (at $50,000, $100,000, $150,000, and $200,000 per evLY gained) for baxdrostat and lorundrostat when compared to each comparator to estimate the percentage of the eligible population that could be treated before reaching the ICER potential budget impact threshold of $821 million.” (opens the source at this quote in a new tab)
ICER dosing regimens costed
Lorundrostat price: manufacturer statements
Comparator acquisition cost: National Average Drug Acquisition Cost, spironolactone 25 mg
Comparator acquisition cost: National Average Drug Acquisition Cost, eplerenone 50 mg
Comparator acquisition cost: National Average Drug Acquisition Cost, amiloride 5 mg
Comparator acquisition cost: National Average Drug Acquisition Cost, baxdrostat 2 mg